Baidu
map
J CLIN PHARMACOL 润色咨询

JOURNAL OF CLINICAL PHARMACOLOGY

出版年份：1973 年文章数：2730 投稿命中率： 开通期刊会员，数据随心看

出版周期：Monthly 自引率：4.4% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=1092809, encodeId=19ad109280925, content=如何回复评审的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092810, encodeId=5de01092810b1, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858809, encodeId=347d85880991, content=审稿速度:1.0<br>经验分享：journal of clinical pharmacology<br> 投稿至录用40天，中间大修小修各一次。<br> 2.15 投稿,一直显示awaiting reviewers assign, <br> 3.23 状态一直是awaiting reviewers assign，收到邮件，大修<br> 3.24 修回<br> 3.25 小修<br> 3.26 接收<br> 总的来说，效率挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Fri Mar 27 05:44:44 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563592, encodeId=fa415635922f, content=请问这个杂志有被SCI收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FfbkHQf9AZPd2xzGBicqzCgXgzbYKJ2I97X7m43GoGEzuCnluOOPovkfn0JQBicO3x8ERnK4pUZGtdic2iaBYMZiaAw/132, createdBy=ef6d2381493, createdName=梅梅梅666, createdTime=Sat Nov 24 16:41:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539593, encodeId=a1f0539593ea, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492415, encodeId=144549241575, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2021-12-28 MS54455111222

    如何回复评审的意见？

    1

    展开1条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=1092809, encodeId=19ad109280925, content=如何回复评审的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092810, encodeId=5de01092810b1, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858809, encodeId=347d85880991, content=审稿速度:1.0<br>经验分享：journal of clinical pharmacology<br> 投稿至录用40天，中间大修小修各一次。<br> 2.15 投稿,一直显示awaiting reviewers assign, <br> 3.23 状态一直是awaiting reviewers assign，收到邮件，大修<br> 3.24 修回<br> 3.25 小修<br> 3.26 接收<br> 总的来说，效率挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Fri Mar 27 05:44:44 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563592, encodeId=fa415635922f, content=请问这个杂志有被SCI收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FfbkHQf9AZPd2xzGBicqzCgXgzbYKJ2I97X7m43GoGEzuCnluOOPovkfn0JQBicO3x8ERnK4pUZGtdic2iaBYMZiaAw/132, createdBy=ef6d2381493, createdName=梅梅梅666, createdTime=Sat Nov 24 16:41:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539593, encodeId=a1f0539593ea, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492415, encodeId=144549241575, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2021-12-27 Gym璨烨

    如何回复期刊编辑的意见？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=1092809, encodeId=19ad109280925, content=如何回复评审的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092810, encodeId=5de01092810b1, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858809, encodeId=347d85880991, content=审稿速度:1.0<br>经验分享：journal of clinical pharmacology<br> 投稿至录用40天，中间大修小修各一次。<br> 2.15 投稿,一直显示awaiting reviewers assign, <br> 3.23 状态一直是awaiting reviewers assign，收到邮件，大修<br> 3.24 修回<br> 3.25 小修<br> 3.26 接收<br> 总的来说，效率挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Fri Mar 27 05:44:44 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563592, encodeId=fa415635922f, content=请问这个杂志有被SCI收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FfbkHQf9AZPd2xzGBicqzCgXgzbYKJ2I97X7m43GoGEzuCnluOOPovkfn0JQBicO3x8ERnK4pUZGtdic2iaBYMZiaAw/132, createdBy=ef6d2381493, createdName=梅梅梅666, createdTime=Sat Nov 24 16:41:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539593, encodeId=a1f0539593ea, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492415, encodeId=144549241575, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2020-03-27 ms6291048970344522

    审稿速度:1.0
    经验分享：journal of clinical pharmacology
    投稿至录用40天，中间大修小修各一次。
    2.15 投稿,一直显示awaiting reviewers assign,
    3.23 状态一直是awaiting reviewers assign，收到邮件，大修
    3.24 修回
    3.25 小修
    3.26 接收
    总的来说，效率挺快的

    3

    展开3条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=1092809, encodeId=19ad109280925, content=如何回复评审的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092810, encodeId=5de01092810b1, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858809, encodeId=347d85880991, content=审稿速度:1.0<br>经验分享：journal of clinical pharmacology<br> 投稿至录用40天，中间大修小修各一次。<br> 2.15 投稿,一直显示awaiting reviewers assign, <br> 3.23 状态一直是awaiting reviewers assign，收到邮件，大修<br> 3.24 修回<br> 3.25 小修<br> 3.26 接收<br> 总的来说，效率挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Fri Mar 27 05:44:44 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563592, encodeId=fa415635922f, content=请问这个杂志有被SCI收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FfbkHQf9AZPd2xzGBicqzCgXgzbYKJ2I97X7m43GoGEzuCnluOOPovkfn0JQBicO3x8ERnK4pUZGtdic2iaBYMZiaAw/132, createdBy=ef6d2381493, createdName=梅梅梅666, createdTime=Sat Nov 24 16:41:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539593, encodeId=a1f0539593ea, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492415, encodeId=144549241575, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2018-11-24 梅梅梅666

    请问这个杂志有被SCI收录吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1092809, encodeId=19ad109280925, content=如何回复评审的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092810, encodeId=5de01092810b1, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858809, encodeId=347d85880991, content=审稿速度:1.0<br>经验分享：journal of clinical pharmacology<br> 投稿至录用40天，中间大修小修各一次。<br> 2.15 投稿,一直显示awaiting reviewers assign, <br> 3.23 状态一直是awaiting reviewers assign，收到邮件，大修<br> 3.24 修回<br> 3.25 小修<br> 3.26 接收<br> 总的来说，效率挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Fri Mar 27 05:44:44 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563592, encodeId=fa415635922f, content=请问这个杂志有被SCI收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FfbkHQf9AZPd2xzGBicqzCgXgzbYKJ2I97X7m43GoGEzuCnluOOPovkfn0JQBicO3x8ERnK4pUZGtdic2iaBYMZiaAw/132, createdBy=ef6d2381493, createdName=梅梅梅666, createdTime=Sat Nov 24 16:41:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539593, encodeId=a1f0539593ea, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492415, encodeId=144549241575, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2017-07-18 chengqi2017

    一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1092809, encodeId=19ad109280925, content=如何回复评审的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=93, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=71734776539, createdName=MS54455111222, createdTime=Tue Dec 28 14:52:49 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1092810, encodeId=5de01092810b1, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=edd01701426, createdName=Gym璨烨, createdTime=Mon Dec 27 14:52:49 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=858809, encodeId=347d85880991, content=审稿速度:1.0<br>经验分享：journal of clinical pharmacology<br> 投稿至录用40天，中间大修小修各一次。<br> 2.15 投稿,一直显示awaiting reviewers assign, <br> 3.23 状态一直是awaiting reviewers assign，收到邮件，大修<br> 3.24 修回<br> 3.25 小修<br> 3.26 接收<br> 总的来说，效率挺快的 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=195, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=04b15414042, createdName=ms6291048970344522, createdTime=Fri Mar 27 05:44:44 CST 2020, time=2020-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563592, encodeId=fa415635922f, content=请问这个杂志有被SCI收录吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=264, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/FfbkHQf9AZPd2xzGBicqzCgXgzbYKJ2I97X7m43GoGEzuCnluOOPovkfn0JQBicO3x8ERnK4pUZGtdic2iaBYMZiaAw/132, createdBy=ef6d2381493, createdName=梅梅梅666, createdTime=Sat Nov 24 16:41:00 CST 2018, time=2018-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539593, encodeId=a1f0539593ea, content=一切只能希望明年,毕竟整体在涨就不用担心。哪怕一年只涨一点点，日积月累，也是不错的, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=378, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chengqi2017, createdTime=Tue Jul 18 18:31:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=492415, encodeId=144549241575, content=明年能不能冲到3分？大家谈谈, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=475, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=qupeter, createdTime=Wed Nov 28 16:24:00 CST 2012, time=2012-11-28, status=1, ipAttribution=)]
    2012-11-28 qupeter

    明年能不能冲到3分？大家谈谈

    0

共11条页码: 1/2页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map